Truace
Subscribe

AI-assisted glaucoma screening in community and primary eye care

Source article: From Algorithm to Care: AI-Assisted Glaucoma Screening in Real-World Settings

Glaucoma screening is increasingly being discussed in the context of artificial intelligence (AI), particularly as imaging technologies become more accessible outside specialist clinics.The question, however, is not simply whether AI can identify a suspicious optic nerve head, but whether it can contribute to a screening pathway that works in real-world clinical settings.Fundus image-based AI has shown promising performance and is now being explored in community and primary eye care.The clinical value of these a…

By the Truvace desk2 min read1 sourcePeer-reviewedTRV-2026-1474· cite & verify
From Algorithm to Care: AI-Assisted Glaucoma Screening in Real-World Settings
"CRE-003 OphaGo - Retinal Imaging Adapter - Huced Despro ITS" by Djoko Kuswanto is marked with CC0 1.0. To view the terms, visit https://creativecommons.org/publicdomain/zero/1.0/.
Trace impact readingContested
P 72The P score combines the specificity and measured human impact of the grounded problem claim with the strength of this Trace’s cited sources.

Both sides are scored from claims and sources, not community votes.

G 69The G score combines the specificity and measured human impact of the grounded gain claim with the strength of this Trace’s cited sources.

In brief

This commentary examines how artificial intelligence applied to fundus images could support glaucoma screening outside specialist clinics. It notes that algorithm performance has looked promising, but argues that the real test is whether screening works within routine care pathways.

The practical significance is that detecting a suspicious optic nerve head is not the same as helping a patient. Benefits depend on image quality, sensible targeting of who is screened, and whether people follow through on referral. How well these pathways work in practice remains to be established.

Main points

  1. Fundus image-based AI has shown promising performance and is being explored in community and primary eye care.
  2. Media opacity and poor-quality images can limit assessment of screened eyes.
  3. Indiscriminate screening can generate unnecessary referrals, and many flagged patients may not complete referral.
  4. AI is framed as one part of a screening strategy, not a replacement for clinical assessment.
  5. Success is defined by timely diagnosis, treatment, and ongoing care for people with previously undetected glaucoma.

The gain

Fundus image-based AI has shown promising performance and is being explored in community and primary eye care, extending glaucoma screening beyond specialist clinics.

The problem

Poor image quality, unnecessary referrals from indiscriminate screening, and incomplete referral follow-through can prevent AI-flagged glaucoma risk from becoming timely diagnosis and treatment.

The rundown

The article describes growing interest in AI for glaucoma screening as imaging technologies become more accessible outside specialist clinics. It frames the central question as whether AI can contribute to a screening pathway that works in real-world settings, rather than only whether it can identify a suspicious optic nerve head.

It lists several practical barriers: media opacity and poor-quality images limit assessment, indiscriminate screening can produce unnecessary referrals, and many people identified as needing evaluation may not complete the referral pathway.

To improve efficiency, the text suggests risk-based selection, early recognition of ungradable images, and appropriate management of visually significant cataracts or other media opacity. Portable or tablet-based visual field testing could add functional assessment in primary care, though its role is not yet established.

The author argues future work should focus less on isolated performance metrics and more on where the technology fits within existing eye care services.

What this doesn’t fix

The source states that the role of portable or tablet-based visual field testing at the primary-care level remains to be established, so parts of the proposed screening strategy are unproven.

Sources

  1. Peer-reviewedCureus2026-10-14

The debate